Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This is a Phase II/III study. Patient population is adult participants with PSMA-positive mCRPC who had treatments with androgen receptor pathway inhibitor (ARPI) and taxane-based chemotherapy and progressed on or after \[177Lu\]Lu-PSMA targeted therapy. Treatment of interest: the investigational treatment is AAA817 regardless of subsequent anti-neoplastic treatment. The control treatment is investigator's choice of Standard of Care, regardless of subsequent anti-neoplastic treatment
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this prostate cancer clinical trial in Boston, MA
If you're searching for prostate cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.